A Health Economic Evaluation of Sleepio at a Fortune 500 Company

A health economic evaluation of Sleepio was conducted at a Fortune 500 company in collaboration with IBM Watson Health. The cohort of Sleepio users had 28% lower healthcare costs.

Demonstrating $1,677 lower healthcare costs per employee that used Sleepio

A Fortune 500 company, in conjunction with IBM Watson Health, conducted an economic evaluation to test whether our flagship digital sleep improvement program, Sleepio, would lower healthcare costs for their employees.

Individuals who used Sleepio had 28% lower annualized total healthcare costs compared to those who did not use Sleepio — adding to the growing body of financial evidence supporting digital therapeutics. 

Read the white paper
Share article